Michael joined the Board of Alliance as non-executive Chairman in 2004. He had a successful career in corporate finance for over 25 years, having been a director of Hill Samuel and Co and vice-chairman of Charterhouse Bank. Michael graduated in Law from Trinity Hall, Cambridge in 1966 and qualified as a Chartered Accountant in 1969 with Peat, Marwick, Mitchell (now KPMG).

John founded Alliance in 1996. He gained multi-disciplinary experience in the pharmaceutical industry over 30 years.  John held various senior roles at Sandoz (now Novartis) as director of finance and administration and deputy managing director. John has a BSc (Pharmacy) and an MSc (Finance) from the London Business School.

Richard joined the Board of Alliance in 2007. He is a Chartered Accountant with over 15 years of experience in financial roles across a variety of sectors.  Richard read Mathematics at Robinson College, Cambridge and qualified as an accountant with Ernst & Young before joining Somerfield. More recently, he held senior finance positions at FirstGroup and Parragon Publishing.

Tony joined Alliance in 1998. He has had around 30 years’ multi-disciplinary experience in the pharmaceutical and healthcare industries, with positions at Leo Pharma, Glaxo Wellcome (now GSK) and Getinge Industrier. His experience covers the UK and international markets, including overseas positions in India and the Middle East. Tony graduated in Physiology, gained an MBA from Warwick University and is a Chartered Marketer.

Peter was with Cambridge Laboratories from 2004, most recently as UK Commercial Manager, until its acquisition by Alliance in February 2010.  He is a Board Member of the Association of the British Pharmaceutical Industry ("ABPI") and is currently chairman of the ABPI Small Companies Forum.  Prior to joining Cambridge Laboratories, Peter spent six years at GSK, (formally SmithKline Beecham) where he acquired extensive sales and marketing knowledge.  He holds an honours degree in Pharmacology from the University of Edinburgh.

Paul has worked in a legal capacity in the pharmaceutical sector for over 25 years.  He spent the early years of his career as an in-house lawyer for Smith Kline & French and Merck. He is a partner in the international law firm Fasken Martineau and specialises exclusively in the commercial and regulatory aspects of life sciences.

Andrew joined the Board of Alliance in 2006. He has held various senior positions in the pharmaceutical industry throughout the UK and overseas having been managing director and senior vice-president of SmithKline Beecham (now GSK), chief executive of Cerebrus plc until its sale and president international medical marketing services with Parexel International. Andrew is a founder of Novitas BioPharma Consulting. He graduated in natural Sciences from the University of Cambridge.

Thomas joined the board of Alliance as a non-executive director in 2009. He is a partner at MVM Life Science Partners LLP, a life science venture capital fund. He has been an active investor in life sciences since joining MVM in 2002. Before joining MVM, Thomas worked at PricewaterhouseCoopers where he qualified as a Chartered Accountant. Thomas graduated in Molecular and Cellular Biochemistry from the University of Oxford in 1998.